4.7000
+0.1000
+(2.17%)
At close: 3:54:02 PM EST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 6.14M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
BAILEY GREGORY HUGH Director | Purchase at price 4.59 per share. | Direct | 17,745 | Dec 17, 2024 |
BAILEY GREGORY HUGH Director | Purchase at price 6.03 per share. | Direct | 6,851 | Sep 20, 2024 |
BAILEY GREGORY HUGH Director | Purchase at price 6.11 - 6.23 per share. | Direct | 88,257 | Sep 19, 2024 |
MINTZ STEVEN MICHAEL Director | Purchase at price 6.47 per share. | Indirect | 38,814 | Sep 12, 2024 |
BAILEY GREGORY HUGH Director | Purchase at price 8.25 per share. | Direct | 14,652 | Aug 20, 2024 |
BAILEY GREGORY HUGH Director | Purchase at price 6.65 - 7.93 per share. | Direct | 140,116 | Aug 19, 2024 |
MINTZ STEVEN MICHAEL Director | Purchase at price 6.59 per share. | Indirect | 58,928 | Aug 15, 2024 |
BAILEY GREGORY HUGH Director | Purchase at price 7.07 per share. | Direct | 45,228 | Aug 14, 2024 |
MINTZ STEVEN MICHAEL Director | Purchase at price 9.00 - 9.50 per share. | Direct | 70,900 | Jun 25, 2024 |
BAILEY GREGORY HUGH Director | Purchase at price 9.50 per share. | Direct | 60,591 | May 30, 2024 |
BAILEY GREGORY HUGH Director | Purchase at price 9.50 per share. | Direct | 85,680 | May 28, 2024 |
BAILEY GREGORY HUGH Director | Purchase at price 9.50 per share. | Direct | 31,226 | May 23, 2024 |
BAILEY GREGORY HUGH Director | Purchase at price 9.50 per share. | Direct | 13,509 | May 21, 2024 |
MINTZ STEVEN MICHAEL Director | Purchase at price 8.50 - 10.00 per share. | Indirect | 120,827 | May 21, 2024 |
BAILEY GREGORY HUGH Director | Purchase at price 9.00 per share. | Direct | 900 | May 20, 2024 |
JUVENESCENCE LTD. Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Mar 14, 2023 |
WEST MICHAEL D Chief Executive Officer | -- | Direct | -- | Mar 10, 2023 |
Related Tickers
EPRX Eupraxia Pharmaceuticals Inc.
2.8957
-3.48%
RADX Radiopharm Theranostics Limited
4.6400
-3.93%
INTS Intensity Therapeutics, Inc.
2.2100
-1.78%
INDP Indaptus Therapeutics, Inc.
0.9100
-2.67%
30J.SG IDEAYA Biosciences, Inc.
23.20
+3.57%
PBN.F Alterity Therapeutics Limited
0.0090
-5.26%
PRTG Portage Biotech Inc.
4.4100
-3.29%
LCTX Lineage Cell Therapeutics, Inc.
0.6007
-4.12%
2257.HK Sirnaomics Ltd.
2.890
+4.33%
PRNAF Alterity Therapeutics Limited
0.0101
0.00%